Latest Healthcare Policy news from across the web.
Detailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall survival, from 13.2 months to 6.7 months
Read full article →“You have to understand a person's belief if you want to address it,” Deva Sharma says on the “First Opinion Podcast” about requests for unvaccinated donor blood.
Read full article →Eli Lilly announces two China deals, Akeso's lung cancer bispecific payoff, and more biotech news from The Readout
Read full article →The Trump administration disregards infectious disease playbook, CEPI offers vaccine funding, and other health news from Morning Rounds
Read full article →The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion upfront.
Read full article →A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
Read full article →The arbitration process has protected patients but generated financial windfalls for some clinicians.
Read full article →A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using peptides.
Read full article →Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing how much this will cost taxpayers.
Read full article →Two years after General Catalyst said it was buying Ohio safety-net hospital Summa Health, executives shed light on how the “transformation” is going.
Read full article →Why are residency programs disciplining and dismissing trainees in a system funded to train them?
Read full article →Congress must incentivize more physicians (and their employers) to join the military medical corps, writes the former attending physician to Congress.
Read full article →